TRACEY ALVES: Open Payments
NPI 1780038869 · UNION, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,432 in 75 payments from 20 companies in 2025. Trend: 2023 $417 · 2024 $837 · 2025 $1,432
Food & beverage: $1,432
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 15 | $393 |
| Celltrion USA Inc. | 9 | $165 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $139 |
| Ardelyx, Inc. | 5 | $92 |
| Novo Nordisk Inc | 5 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $87 |
| ABBVIE INC. | 5 | $84 |
| PFIZER INC. | 4 | $70 |
| Phathom Pharmaceuticals, Inc. | 4 | $60 |
| Janssen Biotech, Inc. | 2 | $42 |
Products named: REZDIFFRA, VEGZELMA, XIFAXAN, IBSRELA, Wegovy, RINVOQ, ENTYVIO, VOQUEZNA.
Industry payments across NJ — which companies pay providers there.
